FREYR Battery Inc (FREY) stock saw a decline, ending the day at $2.58 which represents a decrease of $-0.12 or -4.44% from the prior close of $2.7. The stock opened at $2.71 and touched a low of $2.45 ...
BTIG analyst Julian Harrison initiated coverage with a Buy rating on VYNE Therapeutics (VYNE – Research Report) on December 30 and set a price target of $8.00. The company’s shares closed yesterday at ...
BTIG notes that Casago has agreed to acquire Neutral-rated Vacasa (VCSA) for $5.02/share in cash with the deal expected to close Q1-Q2 2025.
BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...
On Tuesday, Vuzix Corp (VUZI) stock saw a decline, ending the day at $3.94 which represents a decrease of $-0.38 or -8.80% from the prior close of $4.32. The stock opened at $4.41 and touched a low of ...
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...
Jonathan Krinsky, BTIG chief market technician, joins 'Closing Bell' to discuss why he's cautious on Apple and the market ...
SunCar Technology Group (NASDAQ:SDA) is on watch after BTIG Research initiated coverage on the cloud-based provider of digitalized automotive services and auto e-insurance solutions with a Buy rating.
Equities research analysts at BTIG Research assumed coverage on shares of SunCar Technology Group (NASDAQ:SDA – Get Free ...
It isn’t all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech’s XLK 1.5% fall makes it by far the worst-performing S&P 500 sector and is a concern ...
According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...
BTIG analyst Jeet Mukherjee initiated coverage of Arvinas (ARVN) with a Buy rating and $69 price target The company’s lead program, vepdegestrant, is a potent ER degrader for being developed for ...